Download PDF
Thromb Haemost 1962; 07(01): 048-069
DOI: 10.1055/s-0038-1655455
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Significance of the Hageman-Factor for the Effect of Wettable Surface on Thrombocytes[*]

J Jürgens
1   II. Med. Univ. Clinic frankfurt (M.) (Head: Prof. Dr. J. Frey)
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

  PDF Download  Permissions and Reprints

Summary

1. Disintegration of thrombocytes through contact with wettable surfaces — precipitated in the glass rotator in the form of platelet agglomeration — demands the presence of the Hageman-factor, prothrombin and the fibrinogen on the surface of the thrombocytes.

2. For the precipitation of platelet-agglomeration and -disintegration through contact with glass, activation of the complete preliminary phase of blood coagulation is not essential. The process also takes place in the absence of factors V, VIII, IX and X and possibly also without the influence of PTA.

3. On the basis of the present results it can therefore be assumed that disintegration of the thrombocytes through wettable surfaces is brought about by activation of the Hageman-factor on wettable surfaces alone. The activated Hageman-factor probably reacts directly with prothrombin, which leads to sufficient activation of thrombin to cause an increase in adhesiveness and agglomeration of the thrombocytes.

4. This especial thrombocyte disintegration sequence may proceed directly or indirectly. Calcium ions are not essential to either form. Herein lies the fundamental difference to the activation of factor IX through glass contact. Here the direct mechanism does not require calcium ions, whereas these are indispensable for indirect activation.

5. For the activation of the intrinsic system of the plasma, PTA as an intermediary product is most probably indispensable, whereas this is not the case for the precipitation of platelet disintegration through glass contact.

6. The reason why factor IX is not essential to the precipitation of platelet disintegration may be either that the process requires only traces of thrombin, or that disintegration of the platelets is induced already by intermediary products. The precipitation of this sequence through slightest traces of thrombin could be explained by the fact that the lack of antithrombin on the surface of the thrombocytes and the presence of platelet factors 2 and 4 exert a thrombin protecting and thrombin potentiating effect.

The observation that platelet disintegration through contact activation with glass surfaces takes place even in the presence of heparin does not contradict the assumption that this process is brought about via thrombin. Although complete activation of the preliminary phase is prevented, the Hageman-principle is nevertheless activated through surface contact and the larger distance between activated surface and intact platelets is bridged over by the fact that the activated principle is not influenced through the heparin milieu. As soon as it reaches the platelet surface, it can, on account of the thrombin protecting effect, react directly with prothrombin.

8. The results of our investigations suggest that, in extremely severe cases of hepatic cirrhosis, the case of the regularly observed disturbance in platelet function (agglomeration, adhesion, retraction of the thrombocytes and rotation thrombelastography) are due, or partly due, to a significant deficiency of the Hageman-factor.

We wish to express our thanks to the Deutsche Forschungsgemeinschaft, Bad Godesberg, for their support in our investigations.

* Dedicated to Prof. Dr. F. Hoff on the occasion of his 65th birthday.


 

  • Literatur

  • 1 Bordet J, Gengou O. Recherches sur la coagulation du sang. Ann. Inst. Pasteur Lille 1930; 17: 822
    PubMedGoogle Scholar
  • 2 Hirschboeck J. Delayed Blood Coagulation and Absence of Clot Retraction in Collodion Lined Vessels. Proc. Soc. exp. Biol. (N. Y.) 1940; 45: 122
    CrossrefPubMedGoogle Scholar
  • 3 Lenggenhager K. über die Entstehung. Erkennung und Vermeidung der postoperativen Fernthrombose Thieme; Stuttgart: 1948
    Google Scholar
  • 4 Tocantins L. M. Influence of the contacting surface on the coagulability and anticephalin activity of normal and hemophilic plasma. Amer. J. Physiol 1945; 143: 67
    PubMedGoogle Scholar
  • 5 Fiala S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch. int. Physiol 1951; 58: 386
    PubMedGoogle Scholar
  • 6 Lozner E. L, Taylor F. H, McDonald H. The effect of foreign surfaces on blood coagulation. J. clin. Invest 1942; 21: 241
    CrossrefPubMedGoogle Scholar
  • 7 Quick A. J, Epstein E. Thromboplastic Activity in Human Blood. J. appl. Physiol 1952; 4: 840
    CrossrefPubMedGoogle Scholar
  • 8 Conley C. L, Hartmann R. C, Morse W. I. The Clotting Behaviour of Human “Platelet-Free” Plasma: Evidence for the Existence of a “Plasma Thromboplastin”. J. clin. Invest 1949; 28: 340
    CrossrefPubMedGoogle Scholar
  • 9 Ratnoff O. D, Conley C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull. Johns Hopk. Hosp 1951; 89: 245
    PubMedGoogle Scholar
  • 10 Hartmann C. R, Conley C. L, Lalley J. S. Studies on the initiation of blood coagulation. I. The relationship of platelets to the clot-promoting effect of glass surfaces. Bull. Johns Hopk. Hosp 1949; 85: 231
    PubMedGoogle Scholar
  • 11 Biggs R, Douglas A. S, Macfarlane R. G. The initial stages of blood coagulation. J. Physiol 1953; 122: 538
    CrossrefPubMedGoogle Scholar
  • 12 Biggs R, Douglas A. S, Macfarlane R. G. Christmas disease. A condition previously mistaken for haemophilia. Brit. med. J 1952: 1378
    PubMedGoogle Scholar
  • 13 Ratnoff O. D, Colopy J. E. A familial hemorrhagic trait associated with a deficiency of a clot promoting fraction of plasma. J. clin. Invest 1955; 34: 602
    CrossrefPubMedGoogle Scholar
  • 14 Ramont B, Singer K, Heller P, Zimmermann H. J. Hageman factor (HF) deficiency. Blood 1956; 11: 745
    PubMedGoogle Scholar
  • 15 Frick P. G, Hagen P. S. Severe coagulation defect without hemorrhagic symptoms caused by a deficiency of the fifth plasma thromboplastin precursor. J. Lab. clin. Med 1946; 47: 592
    PubMedGoogle Scholar
  • 16 Jim R. T. S, Goldfein S. Hageman-Trait (Hageman Factor Deficiency). Amer. J. Med 1957; 23: 824
    CrossrefPubMedGoogle Scholar
  • 17 Soulier J. P, Wartelle O, Ménaché D. Hageman-Trait and PTA deficiency; the role of contact of blood with glass. Rev. franc. ét. clin. biol 1958; 3: 263
    PubMedGoogle Scholar
  • 18 Ratnoff O. D. A familial trait characterized by deficiency of a clot-promoting fraction of plasma. J. Lab. Clin. Med 1954; 44: 915
    PubMedGoogle Scholar
  • 19 Ratnoff O. D, Margolius A. Hageman-Trait: an asymptomatic disorder of blood coagulation. Trans. Ass. Amer. Physiol 1955; 68: 149
    PubMedGoogle Scholar
  • 20 Caen J, Bernard J. Déficit en facteur Hageman. Rev. Hémat 1958; 13: 154-162. 154-162 (1958)
    PubMedGoogle Scholar
  • 21 Johnston C. L, Ferguson J. H, O’Hanlon F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc. Soc. exp. Biol. (N. Y.) 1958; 99: 197
    CrossrefPubMedGoogle Scholar
  • 22 Larrieu M. J, Soulier J. P, Culot Y. Déficit en facteur Hageman. Sang 1957; 28: 152
    PubMedGoogle Scholar
  • 23 Margolius A, Ratnoff O. D. Observations on the hereditary nature of Hagemantrait. Blood 1956; 11: 565
    PubMedGoogle Scholar
  • 24 Ratnoff O. D, Rosenblum J. M. The role of Hageman factor in the initiation of clotting by glass. J. Lab. clin. Med 1956; 47: 592
    PubMedGoogle Scholar
  • 25 Loeliger E. A, Hensen A. Coagulation Studies in a Case of Hageman-Trait initial stages of blood coagulation. Thromb. Diath. haem 1960; 5: 187
    PubMedGoogle Scholar
  • 26 Soulier J. P, Larrieu M. J. Déficit en 3ème factor prothromboplastique plasmatique. Rapports entre le PTA et le facteur Hageman. Thromb Diath. haem 1958; 2: 1
    PubMedGoogle Scholar
  • 27 Haanen C, Hommes F, Benraad H, Morselt G. A Case of HagemanFactor Deficiency and a Method to Purify the Factor. Thromb. Diath. haem 1960; 5: 201
    PubMedGoogle Scholar
  • 28 Wright I. S, Koller F, Streuli F. New blood clotting factors. Thromb. Diath. haem. (Suppl.) IV 1960
    Google Scholar
  • 29 Rapaport S. I, Aas K, Owren P. A. The Effect of Glass upon the Activity of the Various Plasma Clotting Factors. J. clin. Invest 1955; 34: 9
    CrossrefPubMedGoogle Scholar
  • 30 Soulier J.-P, Wartelle O, Ménaché D. Hageman-Trait and PTA Deficiency; the Role of Contact of Blood with Glass. Brit. J. Haemat 1959; 5: 121
    CrossrefPubMedGoogle Scholar
  • 31 Margolis J. Initiation of blood coagulation by glass and related surfaces. J. Physiol 1957; 137: 95
    CrossrefPubMedGoogle Scholar
  • 32 Margolis J. Hageman-factor in plasma foreign surface reactions. Nature (Lond.) 1958; 182: 1102
    CrossrefPubMedGoogle Scholar
  • 33 Hardisty R. M, Margolis J. The role of Hageman-factor in the initiation of blood coagulation. Brit. J. Haemat 1959; 5: 203
    CrossrefPubMedGoogle Scholar
  • 34 Haanen, Hommes, Benrad, Morselt A Case of Hageman-factor Deficiency and a Method the Purify the Factor. Thromb. Diath. haem 1960; 5: 201
    PubMedGoogle Scholar
  • 35 Egli H. PersÖnl. Mitteilung. — Zur Differenzierung und Kalziumabhängigkeit von Kontaktwirkung benetzbarer Oberflächen. Thromb. Diath. haem 1959; 3: 604
    PubMedGoogle Scholar
  • 36 Roskam J. 1. Symp. Fond. V. Baldacci, Madrid 1953. — 2. Symp. Fond. V. Baldacci, Seteais 1956. — 3. Symp. Fond. V. Baldacci, Formentor 1960. Ed. Omnia Medica, Pisa.
    PubMed
  • 37 Bounameaux Y. 2. Symp. Fond. V. Baldacci, Seteais 1956. Ed. Omnia Medica, Pisa.
    PubMed
  • 38 Owren P. II. Symp. Fond. V. Baldacci, Seteais 1956. — III. Symp. Fond. V. Baldacci, Formentor 1960. Ed. Omnia Medica, Pisa.
    PubMed
  • 39 Salmon J, Bounameaux Y. études immunoélectrophorétiques des antigènes plaquettaires humains. C. R. Soc. Biol. (Paris) 1956; 150: 2278
    PubMedGoogle Scholar
  • 40 Seligmann M. B. et al. études immunochimiques sur la présence de fibrinogène dans les extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev. Hémat 1957; 12: 302
    PubMedGoogle Scholar
  • 41 Lüscher E. F. Thrombozytenfaktoren Ergebn. Physiol 1959; 50: 1
    PubMedGoogle Scholar
  • 42 Sokal G. Plaquettes Sanguines Et Structure Du Caillot. Ed. S. A. Arsia; Bruxelles: 1960
    Google Scholar
  • 43 Bounameaux Y. Sur Le Mécanisme De La Rétraction Du Caillot Et De La Métamorphose Visqueuse Des Plaquettes. Rev. Hémat 1957; 12: 16
    PubMedGoogle Scholar
  • 44 Johnson S. H, Schneider Ch. L. The existence of antifibrinolysin activity in platelets. Science 1953; 117: 229
    CrossrefPubMedGoogle Scholar
  • 45 Wright H. P. The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. Lancet 1956: 306
    PubMedGoogle Scholar
  • 46 Jürgens J, Beller F. K. Klinische Methoden der Blutgerinnungsanalyse. Thieme; Stuttgart: 1959
    Google Scholar
  • 47 Macfarlane R. G. A simple method for measuring clot retraction. Lancet 1939: 199
    PubMedGoogle Scholar
  • 48 Hartert H. Die Thrombelastographie. Eine Methode zur physikalischen Analyse des Blutgerinnungsvorganges. 2. ges. exp. Med 1951; 117: 189
    PubMedGoogle Scholar
  • 49 Hitzig W. H. Neue Methode zur Thrombozytenisolierung. Schweiz. med. Wschr 1954: 1126
    PubMedGoogle Scholar
  • 50 Soulier J.P. Fractions Coagulantes Préparées— A Partir Du Plasma Humain. Path. Biol 1959; 7: 2439
    PubMedGoogle Scholar
  • 51 Egli H, Buscha H. Zur Differenzierung und Kalziumabhängigkeit von Kontaktwirkungen benetzbarer Oberflächen. Ihr Einfluß auf die Blutthrombokinasebildung. Thromb. Diath. haem 1954; 3: 604
    PubMedGoogle Scholar
  • 52 Biggs R, Douglas A. S, Macfarlane R. G. The formation of thromboplastin in human blood. J. Physiol 1953; 119: 89
    CrossrefPubMedGoogle Scholar
  • 53a Jürgens J. II. Symp. Fond. V. Baldacci, Seteais. 1957. Ed. Omnia Medica; Pisa.:
    Google Scholar
  • 53b Jürgens J. III. Symp. Fond. V. Baldacci, Formentor, Mallorca. 1960. Ed. Omnia Medica; Pisa:
    Google Scholar
  • 53c Jürgens J. Symp. on Platelets. Henry Ford-Hosp; Detroit: 1960
    Google Scholar
  • 53d Jürgens J. über die Ursache der Blutungsneigung bei der Makroglobulinämie WaldenstrÖm. Verh. dtsch. Ges. inn. Med., 62. Kongr. 1956
    PubMedGoogle Scholar
  • 54 Ollendorff P. Platelet Activity and Activation of Blood Clotting by Glass. Thromb. Diath. haem 1960; 4: 410
    PubMedGoogle Scholar
  • 55 Marx R. Zur Trennung thrombozytogener und thrombozytotroper Gerinnungsfaktoren. Proc. VII Congr. Intern. Soc. Blood Transf., Rom 1958
    Google Scholar